The effects of benzodiazepines on urotensin ii-stimulated norepinephrine release from rat cerebrocortical slices

Anesthesia and Analgesia

Volumn 108, Issue 4, 2009, Pages 1177-1181

  Kawaguchi, Yoko ^a   Ono, Tomoko ^a   Kudo, Mihoko ^a   Kushikata, Tetsuya ^a   Hashiba, Eiji ^a   Yoshida, Hitoshi ^a   Kudo, Tsuyoshi ^a   Furukawa, Kenichi ^b   Douglas, Stephen A ^a   Hirota, Kazuyoshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; DIAZEPAM; FLUNITRAZEPAM; MIDAZOLAM; UROTENSIN II; 1 (2 METHYLBENZOXAZOL 6 YL) 3 (1,5)NAPHTHYRIDIN 4 YL UREA; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE; BENZOXAZOLE DERIVATIVE; DRUG DERIVATIVE; FLUMAZENIL; G PROTEIN COUPLED RECEPTOR; HYPNOTIC SEDATIVE AGENT; NEUROPEPTIDE RECEPTOR; NORADRENALIN; OREXIN RECEPTORS; UREA; UROTENSIN; UTS2R PROTEIN, RAT;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CALCIUM CELL LEVEL; CELL STRAIN HEK293; CONCENTRATION RESPONSE; DRUG EFFECT; EMBRYO; HUMAN; HUMAN CELL; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CALCIUM SIGNALING; CELL LINE; DOSE RESPONSE; DRUG POTENTIATION; GENETIC TRANSFECTION; GENETICS; IN VITRO STUDY; METABOLISM; SECRETION; WISTAR RAT;

ANIMALS; BENZODIAZEPINES; BENZOXAZOLES; CALCIUM SIGNALING; CELL LINE; CEREBRAL CORTEX; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUMAZENIL; FLUNITRAZEPAM; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GABA-A; RECEPTORS, NEUROPEPTIDE; TRANSFECTION; UREA; UROTENSINS;

EID: 63849273731     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181981faa     Document Type: Article

References (28)

1. McDonald J, Batuwangala M, Lambert DG. Role of urotensin II and its receptor in health and disease. J Anesth 2007;21:378-89
2. Jegou S, Cartier D, Dubessy C, Gonzalez BJ, Chatenet D, Tostivint H, Scalbert E, LePrince J, Vaudry H, Lihrmann I. Localization of the urotensin II receptor in the rat central nervous system. J Comp Neurol 2006;495:21-36
3. do Rego JC, Leprince J, Scalbert E, Vaudry H, Costentin J. Behavioral actions of urotensin-II. Peptides 2008;29:838-44
4. de Lecea L, Bourgin P. Neuropeptide interactions and REM sleep: a role for Urotensin II? Peptides 2008;29:845-51
5. Nakane H, Shimizu N, Hori T. Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis. Am J Physiol 1994;267:R1559-R1566
6. Nieuwenhuys R. Chemoarchitecture of the brain. Berlin, Springer-Verlag, 1985
7. Matsumoto Y, Abe M, Watanabe T, Adachi Y, Yano T, Takahashi H, Sugo T, Mori M, Kitada C, Kurokawa T, Fujino M. Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents. Neurosci Lett 2004;358:99-102
8. Watson AM, May CN. Urotensin II, a novel peptide in central and peripheral cardiovascular control. Peptides 2004;25:1759-66
9. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 1998;438:71-5
10. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Roultledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA, Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999;96:10911-16
11. Dong HL, Fukuda S, Murata E, Zhu Z, Higuchi T. Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia. Anesthesiology 2006;104:1023-32
12. Hirota K, Kushikata T, Kudo M, Kudo T, Smart D, Matsuki A. Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Res 2003;981:143-50
13. Hirota K, Kushikata T, Kudo M, Kudo T, Lambert DG, Matsuki A. Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br J Pharmacol 2001;134:1461-6
14. Finlay JM, Zigmond MJ, Abercrombie ED. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 1995;64:619-28
15. Kubota T, Hirota K, Yoshida H, Takahashi S, Anzawa N, Ohkawa H, Kushikata T, Matsuki A. Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats. Psychopharmacology (Berl) 1999;146:335-8
16. He Y, Kudo M, Kudo T, Kushikata T, Li E, Hirota K. The effects of benzodiazepines on orexinergic systems in rat cerebrocortical slices. Anesth Analg 2007;104:338-40
17. Ono T, Kawaguchi Y, Kudo M, Kushikata T, Hashiba E, Yoshida H, Kudo T, Furukawa K, Douglas SA, Guerrini R, Calo' G, Lambert DG, Hirota K. Urotensin II evokes neurotransmitter release from rat cerebrocortical slices. Neurosci Lett 2008;440:275-9
18. Sawada M, Ichinose M. Potentiation of GABAA receptormediated Cl- current by urotensin peptides in identified Aplysia neurons. J Neurosci Res 1999;56:547-52
19. Wu YM, Wang R, He RR. Urotensin II inhibits electrical activity of hippocampal CA1 neurons by potentiating the GABAA receptor-mediated Cl- current. Neurosci Bull 2006;22:110-14
20. Desrues L, Lefebvre T, Diallo M, Gandolfo P, Leprince J, Chatenet D, Vaudry H, Tonon MC, Castel H. Effect of GABA A receptor activation on UT-coupled signaling pathways in rat cortical astrocytes. Peptides 2008;29:727-34
21. Lu Y, Zou CJ, Huang DW, Tang CS. Cardiovascular effects of urotensin II in different brain areas. Peptides 2002;23:1631-5
22. Filipeanu CM, Brailoiu E, Le Dun S, Dun NJ. Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons. J Neurochem 2002;83:879-84
23. Horie S, Yasuda S, Tsurumaki Y, Someya A, Saito T, Okuma Y, Nomura Y, Hirabayashi T, Murayama T. Contraction of isolated guinea-pig ileum by urotensin II via activation of ganglionic cholinergic neurons and acetylcholine release. Neuropharmacology 2003;45:1019-27
24. Nakae Y, Kanaya N, Namiki A. The direct effects of diazepam and midazolam on myocardial depression in cultured rat ventricular myocytes. Anesth Analg 1997;85:729-33
25. Hirota K, Kudo M, Kudo T, Matsuki A, Lambert DG. Inhibitory effects of intravenous anaesthetic agents on K--evoked norepinephrine and dopamine release from rat striatal slices: possible involvement of P/Q-type voltage-sensitive Ca2- channels. Br J Anaesth 2000;85:874-80
26. Kollroser M, Schober C. Simultaneous analysis of flunitrazepam and its major metabolites in human plasma by high performance liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 2002;28:1173-82
27. Reves JG, Glass PSA, Lubarsky DA. Nonbarbiturate intravenous anesthetics. In: Miller RD, ed. Anesthesia. 6th ed. New York: Churchill-Livingston, 2005: 228-72
28. Seubert CN, Morey TE, Martynyuk AE, Cucchiara RF, Dennis DM. Midazolam selectively potentiates the A(2A) - but not A1- receptormediated effects of adenosine: role of nucleoside transport inhibition and clinical implications. Anesthesiology 2000;92:567-77